161 related articles for article (PubMed ID: 18759345)
1. Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial.
Boesch S; Sturm B; Hering S; Scheiber-Mojdehkar B; Steinkellner H; Goldenberg H; Poewe W
Mov Disord; 2008 Oct; 23(13):1940-4. PubMed ID: 18759345
[TBL] [Abstract][Full Text] [Related]
2. Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor.
Sturm B; Helminger M; Steinkellner H; Heidari MM; Goldenberg H; Scheiber-Mojdehkar B
Eur J Clin Invest; 2010 Jun; 40(6):561-5. PubMed ID: 20456483
[TBL] [Abstract][Full Text] [Related]
3. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin.
Boesch S; Sturm B; Hering S; Goldenberg H; Poewe W; Scheiber-Mojdehkar B
Ann Neurol; 2007 Nov; 62(5):521-4. PubMed ID: 17702040
[TBL] [Abstract][Full Text] [Related]
4. Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial.
Nachbauer W; Hering S; Seifert M; Steinkellner H; Sturm B; Scheiber-Mojdehkar B; Reindl M; Strasak A; Poewe W; Weiss G; Boesch S
Cerebellum; 2011 Dec; 10(4):763-9. PubMed ID: 21597884
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin in Friedreich ataxia.
Mariotti C; Nachbauer W; Panzeri M; Poewe W; Taroni F; Boesch S
J Neurochem; 2013 Aug; 126 Suppl 1():80-7. PubMed ID: 23859343
[TBL] [Abstract][Full Text] [Related]
6. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
Di Prospero NA; Baker A; Jeffries N; Fischbeck KH
Lancet Neurol; 2007 Oct; 6(10):878-86. PubMed ID: 17826341
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin: effects on frataxin expression in vitro.
Sturm B; Stupphann D; Kaun C; Boesch S; Schranzhofer M; Wojta J; Goldenberg H; Scheiber-Mojdehkar B
Eur J Clin Invest; 2005 Nov; 35(11):711-7. PubMed ID: 16269021
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia.
Boesch S; Nachbauer W; Mariotti C; Sacca F; Filla A; Klockgether T; Klopstock T; Schöls L; Jacobi H; Büchner B; vom Hagen JM; Nanetti L; Manicom K
Mov Disord; 2014 Jun; 29(7):935-9. PubMed ID: 24515352
[TBL] [Abstract][Full Text] [Related]
9. An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.
Yiu EM; Tai G; Peverill RE; Lee KJ; Croft KD; Mori TA; Scheiber-Mojdehkar B; Sturm B; Praschberger M; Vogel AP; Rance G; Stephenson SE; Sarsero JP; Stockley C; Lee CY; Churchyard A; Evans-Galea MV; Ryan MM; Lockhart PJ; Corben LA; Delatycki MB
J Neurol; 2015 May; 262(5):1344-53. PubMed ID: 25845763
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
Mariotti C; Fancellu R; Caldarazzo S; Nanetti L; Di Bella D; Plumari M; Lauria G; Cappellini MD; Duca L; Solari A; Taroni F
Mov Disord; 2012 Mar; 27(3):446-9. PubMed ID: 22411849
[TBL] [Abstract][Full Text] [Related]
11. Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin.
Nachbauer W; Boesch S; Schneider R; Eigentler A; Wanschitz J; Poewe W; Schocke M
PLoS One; 2013; 8(7):e69229. PubMed ID: 23922695
[TBL] [Abstract][Full Text] [Related]
12. Open-label pilot study of interferon gamma-1b in Friedreich ataxia.
Seyer L; Greeley N; Foerster D; Strawser C; Gelbard S; Dong Y; Schadt K; Cotticelli MG; Brocht A; Farmer J; Wilson RB; Lynch DR
Acta Neurol Scand; 2015 Jul; 132(1):7-15. PubMed ID: 25335475
[TBL] [Abstract][Full Text] [Related]
13. Application of a Scale for the Assessment and Rating of Ataxia (SARA) in Friedreich's ataxia patients according to posturography is limited.
Schwabova J; Maly T; Laczo J; Zumrova A; Komarek V; Musova Z; Zahalka F
J Neurol Sci; 2014 Jun; 341(1-2):64-7. PubMed ID: 24768059
[TBL] [Abstract][Full Text] [Related]
14. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
[TBL] [Abstract][Full Text] [Related]
15. GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients.
Marcotulli C; Fortuni S; Arcuri G; Tomassini B; Leonardi L; Pierelli F; Testi R; Casali C
Neurol Sci; 2016 Mar; 37(3):361-4. PubMed ID: 26621361
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Prospects for Friedreich's Ataxia.
Zhang S; Napierala M; Napierala JS
Trends Pharmacol Sci; 2019 Apr; 40(4):229-233. PubMed ID: 30905359
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial.
Arpa J; Sanz-Gallego I; Rodríguez-de-Rivera FJ; Domínguez-Melcón FJ; Prefasi D; Oliva-Navarro J; Moreno-Yangüela M
Acta Neurol Scand; 2014 Jan; 129(1):32-40. PubMed ID: 23668357
[TBL] [Abstract][Full Text] [Related]
18. Triple therapy with darbepoetin alfa, idebenone, and riboflavin in Friedreich's ataxia: an open-label trial.
Arpa J; Sanz-Gallego I; Rodríguez-de-Rivera FJ; Domínguez-Melcón FJ; Prefasi D; Oliva-Navarro J; Moreno-Yangüela M; Pascual-Pascual SI
Cerebellum; 2013 Oct; 12(5):713-20. PubMed ID: 23625326
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxia.
Santner W; Schocke M; Boesch S; Nachbauer W; Egger K
Acta Radiol Short Rep; 2014 May; 3(4):2047981614531573. PubMed ID: 25298866
[TBL] [Abstract][Full Text] [Related]
20. Skeletal muscle involvement in friedreich ataxia and potential effects of recombinant human erythropoietin administration on muscle regeneration and neovascularization.
Nachbauer W; Boesch S; Reindl M; Eigentler A; Hufler K; Poewe W; Löscher W; Wanschitz J
J Neuropathol Exp Neurol; 2012 Aug; 71(8):708-15. PubMed ID: 22805773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
